Sofosbuvir/Velpatasvir for 12 weeks is safe and effective in patients undergoing dialysis

Authors
Category Primary study
JournalCanadian Liver Journal
Year 2019
This article has no abstract
Epistemonikos ID: c5c5d2e754e44098e995b9924cd6a26ef9f443a0
First added on: Feb 11, 2025